Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diseases of the Thyroid

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 127 articles:
HTML format
Text format



Single Articles


    June 2017
  1. ALBUQUERQUE EV, Scalco RC, Jorge AA
    MANAGEMENT OF ENDOCRINE DISEASE: Diagnostic and therapeutic approach of tall stature.
    Eur J Endocrinol. 2017;176:R339-R353.
    PubMed     Text format     Abstract available


  2. DIAMANTI-KANDARAKIS E, Dattilo M, Macut D, Duntas L, et al
    MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview.
    Eur J Endocrinol. 2017;176:R283-R308.
    PubMed     Text format     Abstract available


  3. SCHWENSEN CF, Brandt F, Hegedus L, Brix TH, et al
    Mortality in Graves' orbitopathy is increased and influenced by gender, age and pre-existing morbidity: a nationwide Danish register study.
    Eur J Endocrinol. 2017;176:669-676.
    PubMed     Text format     Abstract available


    May 2017
  4. BLIDDAL S, Boas M, Hilsted L, Friis-Hansen L, et al
    Increase in thyroglobulin antibody and thyroid peroxidase antibody levels, but not preterm birth-rate, in pregnant Danish women upon iodine fortification.
    Eur J Endocrinol. 2017;176:603-612.
    PubMed     Text format     Abstract available


    April 2017
  5. JEON MJ, Kim WG, Kwon H, Kim M, et al
    Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma.
    Eur J Endocrinol. 2017 Apr 21. pii: EJE-17-0160. doi: 10.1530/EJE-17-0160.
    PubMed     Text format     Abstract available


  6. BENJAMENS S, Dullaart RPF, Sluiter WJ, Rienstra M, et al
    The Clinical Value of Regular Thyroid Function Tests During Amiodarone Treatment.
    Eur J Endocrinol. 2017 Apr 19. pii: EJE-17-0018. doi: 10.1530/EJE-17-0018.
    PubMed     Text format     Abstract available


  7. LEGER J, Carel JC
    MANAGEMENT OF ENDOCRINE DISEASE: Arguments for the prolonged use of antithyroid drugs in children with Graves' disease.
    Eur J Endocrinol. 2017 Apr 5. pii: EJE-16-0938. doi: 10.1530/EJE-16-0938.
    PubMed     Text format     Abstract available


  8. ANDERSEN SL, Carle A, Karmisholt JS, Pedersen IB, et al
    MECHANISMS IN ENDOCRINOLOGY: Neurodevelopmental disorders in children born to mothers with thyroid dysfunction. Evidence of fetal programming?
    Eur J Endocrinol. 2017 Apr 4. pii: EJE-16-0947. doi: 10.1530/EJE-16-0947.
    PubMed     Text format     Abstract available


  9. KOREVAAR TI, Peeters RP
    The potential benefit of levothyroxine treatment during pregnancy: another step forward.
    Eur J Endocrinol. 2017;176:C3-C5.
    PubMed     Text format    


  10. VUONG HG, Kondo T, Pham TQ, Oishi N, et al
    Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis.
    Eur J Endocrinol. 2017;176:431-439.
    PubMed     Text format     Abstract available


  11. ROMERO-KUSABARA IL, Filho JV, Scalissi NM, Melo KC, et al
    Distinct inflammatory gene expression in extraocular muscle and fat from patients with Graves' orbitopathy.
    Eur J Endocrinol. 2017;176:481-488.
    PubMed     Text format     Abstract available


    March 2017
  12. CARLE A, Andersen SL, Boelaert K, Laurberg P, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Subclinical Thyrotoxicosis: Prevalence, Causes and Choice of Therapy.
    Eur J Endocrinol. 2017 Mar 8. pii: EJE-16-0276. doi: 10.1530/EJE-16-0276.
    PubMed     Text format     Abstract available


    February 2017
  13. LIU J, Sun W, Dong W, Wang Z, et al
    Risk factors for post-thyroidectomy hemorrhage: a meta- analysis.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0757. doi: 10.1530/EJE-16-0757.
    PubMed     Text format     Abstract available


  14. GIORDA CB, Carna P, Romeo F, Costa G, et al
    Prevalence, incidence, and associated co-morbidities of treated hypothyroidism. An update from a European population.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0559. doi: 10.1530/EJE-16-0559.
    PubMed     Text format     Abstract available


  15. RUGGERI RM, Trimarchi F, Giuffrida G, Certo R, et al
    Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence.
    Eur J Endocrinol. 2017;176:133-141.
    PubMed     Text format     Abstract available


  16. STAN MN, Salvi M
    MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials.
    Eur J Endocrinol. 2017;176:R101-R109.
    PubMed     Text format     Abstract available


    January 2017
  17. TRIMBOLI P, Zilioli V, Imperiali M, Ceriani L, et al
    High-sensitive basal serum thyroglobulin 6-12 months after thyroid ablation is strongly associated with early response to therapy and event-free survival in patients with low to intermediate risk differentiated thyroid carcinomas.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-1011. doi: 10.1530/EJE-16-1011.
    PubMed     Text format     Abstract available


  18. KIM N, Gu JY, Yoo HJ, Han SE, et al
    Contact system activation and high thrombin generation in hyperthyroidism.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-0835. doi: 10.1530/EJE-16-0835.
    PubMed     Text format     Abstract available


  19. ZWAVELING-SOONAWALA N, Witteveen E, Marchal JP, Klouwer F, et al
    Early thyroxine treatment in Down syndrome and thyroid function later in life.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-0858. doi: 10.1530/EJE-16-0858.
    PubMed     Text format     Abstract available


  20. GROZINSKY-GLASBERG S, Bloom A, Lev-Cohain N, Klimov A, et al
    The Role of Hepatic Trans-Arterial Chemoembolization in Metastatic Medullary Thyroid Carcinoma: A Specialist Center Experience and Review of the Literature.
    Eur J Endocrinol. 2017 Jan 18. pii: EJE-16-0960. doi: 10.1530/EJE-16-0960.
    PubMed     Text format     Abstract available


  21. STRUJA T, Kaeslin M, Boesiger F, Jutzi R, et al
    External validation of the GREAT score to predict relapse risk in Graves' disease Results from a multicenter, retrospective study with 741 patients.
    Eur J Endocrinol. 2017 Jan 18. pii: EJE-16-0986. doi: 10.1530/EJE-16-0986.
    PubMed     Text format     Abstract available


  22. KWON H, Jeon MJ, Kim WG, Park S, et al
    A comparison of lobectomy and total thyroidectomy for patients with papillary thyroid microcarcinoma: a retrospective individual risk factor matched cohort study.
    Eur J Endocrinol. 2017 Jan 15. pii: EJE-16-0845. doi: 10.1530/EJE-16-0845.
    PubMed     Text format     Abstract available


  23. DOSIOU C, Medici M
    MANAGEMENT OF ENDOCRINE DISEASE: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns.
    Eur J Endocrinol. 2017;176:R21-R38.
    PubMed     Text format     Abstract available


    December 2016
  24. PERGIALIOTIS V, Konstantopoulos P, Prodromidou A, Florou V, et al
    MANAGEMENT OF ENDOCRINE DISEASE: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis.
    Eur J Endocrinol. 2016 Dec 22. pii: EJE-16-0611. doi: 10.1530/EJE-16-0611.
    PubMed     Text format     Abstract available


  25. WELSH KJ, Soldin SJ
    DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
    Eur J Endocrinol. 2016;175:R255-R263.
    PubMed     Text format     Abstract available


  26. CHAKER L, Sedaghat S, Hoorn EJ, Elzen WP, et al
    The association of thyroid function and the risk of kidney function decline: a population-based cohort study.
    Eur J Endocrinol. 2016;175:653-660.
    PubMed     Text format     Abstract available


  27. WENDLER J, Kroiss M, Gast K, Kreissl MC, et al
    Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
    Eur J Endocrinol. 2016;175:521-529.
    PubMed     Text format     Abstract available


    November 2016
  28. NAZARPOUR S, Ramezani Tehrani F, Simbar M, Tohidi M, et al
    Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease.
    Eur J Endocrinol. 2016 Nov 22. pii: EJE-16-0548.
    PubMed     Text format     Abstract available


  29. RIESCO-EIZAGUIRRE G, Santisteban P
    ENDOCRINE TUMOURS: Advances in the molecular pathogenesis of thyroid cancer: lessons from the cancer genome.
    Eur J Endocrinol. 2016;175:R203-17.
    PubMed     Text format     Abstract available


    October 2016
  30. STRUJA T, Fehlberg H, Kutz A, Guebelin L, et al
    Can we predict relapse in Graves' disease? Results from a Systematic Review and Meta-analysis.
    Eur J Endocrinol. 2016 Oct 25. pii: EJE-16-0725.
    PubMed     Text format     Abstract available


  31. AKIROV A, Gimbel H, Grossman A, Shochat T, et al
    Elevated TSH in adults treated for hypothyroidism is associated with increased mortality.
    Eur J Endocrinol. 2016 Oct 19. pii: EJE-16-0708.
    PubMed     Text format     Abstract available


  32. BOAVENTURA P, Batista R, Pestana A, Reis M, et al
    TERT promoter mutations: A genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation.
    Eur J Endocrinol. 2016 Oct 19. pii: EJE-16-0740.
    PubMed     Text format     Abstract available


  33. DEKKERS OM, Erzsebet Horvath-Puho E, Cannegieter SC, Vandenbroucke J, et al
    Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: population-based cohort study.
    Eur J Endocrinol. 2016 Oct 3. pii: EJE-16-0576.
    PubMed     Text format     Abstract available


  34. BOGUSZEWSKI CL, Ayuk J
    MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and cancer: an old debate revisited.
    Eur J Endocrinol. 2016;175:R147-56.
    PubMed     Text format     Abstract available


    September 2016
  35. BRUSCA N, Virili C, Cellini M, Capriello S, et al
    EARLY DETECTION OF BIOCHEMICALLY OCCULT AUTONOMOUS THYROID NODULES.
    Eur J Endocrinol. 2016 Sep 19. pii: EJE-16-0568.
    PubMed     Text format     Abstract available


  36. DONOVAN P, McLeod D, Little R, Gordon L, et al
    Cost-Utility Analysis Comparing Radioactive Iodine, Antithyroid Drugs and Total Thyroidectomy for Primary Treatment of Graves' Disease.
    Eur J Endocrinol. 2016 Sep 15. pii: EJE-16-0527.
    PubMed     Text format     Abstract available


  37. VELTRI F, Decaillet S, Kleynen P, Grabczan L, et al
    Prevalence of thyroid autoimmunity and dysfunction in women with iron deficiency during early pregnancy: is it altered?
    Eur J Endocrinol. 2016;175:191-9.
    PubMed     Text format     Abstract available


  38. CAMPI I, Vannucchi G, Salvi M
    THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves' orbitopathy.
    Eur J Endocrinol. 2016;175:R117-33.
    PubMed     Text format     Abstract available


    August 2016
  39. CAVARZERE P, Camilot M, Popa FI, Lauriola S, et al
    CONGENITAL HYPOTHYROIDISM WITH DELAYED TSH ELEVATION IN LOW BIRTH WEIGHT INFANTS: INCIDENCE, DIAGNOSIS AND MANAGEMENT.
    Eur J Endocrinol. 2016 Aug 10. pii: EJE-15-1233.
    PubMed     Text format     Abstract available


  40. ANDERSEN SL, Carle A, Olsen J, Laurberg P, et al
    Hypothyroidism incidence in and around pregnancy: A Danish nationwide study.
    Eur J Endocrinol. 2016 Aug 10. pii: EJE-16-0446.
    PubMed     Text format     Abstract available


  41. KUKULSKA A, Krajewska J, Kolosza Z, Paliczka-Cieslik E, et al
    The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice.
    Eur J Endocrinol. 2016 Aug 10. pii: EJE-16-0360.
    PubMed     Text format     Abstract available


  42. LIAMIS G, Filippatos TD, Liontos A, Elisaf MS, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: Mechanisms, implications and treatment.
    Eur J Endocrinol. 2016 Aug 2. pii: EJE-16-0493.
    PubMed     Text format     Abstract available


    July 2016
  43. HOLOVACOVA D, Kuzma M, Killinger Z, Payer J, et al
    Cross-sectional area of the median nerve is increased in primary autoimmune hypothyroidism and decreases upon treatment with thyroxine.
    Eur J Endocrinol. 2016 Jul 14. pii: EJE-16-0397.
    PubMed     Text format     Abstract available


  44. MOTAMED B, Eftekharzadeh A, Hosseinpanah F, Tohidi M, et al
    The relation between changes in thyroid function and anthropometric indices during long term follow up of euthyroid subjects; the Tehran Thyroid Study (TTS).
    Eur J Endocrinol. 2016 Jul 11. pii: EJE-16-0414.
    PubMed     Text format     Abstract available


  45. ROUCHER-BOULEZ F, Mallet-Motak D, Samara-Boustani D, Jilani H, et al
    NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.
    Eur J Endocrinol. 2016;175:73-84.
    PubMed     Text format     Abstract available


    June 2016
  46. MACHENS A, Dralle H
    Surgical Cure Rates of Sporadic Medullary Thyroid Cancer in the Era of Calcitonin Screening.
    Eur J Endocrinol. 2016 Jun 22. pii: EJE-16-0325.
    PubMed     Text format     Abstract available


  47. TIEDJE V, Ting S, Walter RF, Herold T, et al
    Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients.
    Eur J Endocrinol. 2016 Jun 9. pii: EJE-16-0252.
    PubMed     Text format     Abstract available


  48. LAURBERG P, Andersen SL
    ENDOCRINOLOGY IN PREGNANCY: Pregnancy and the incidence, diagnosing and therapy of Graves' disease.
    Eur J Endocrinol. 2016 Jun 8. pii: EJE-16-0410.
    PubMed     Text format     Abstract available


  49. CHOI YM, Kim WG, Kwon H, Jeon MJ, et al
    Early Prognostic Factors at the time of diagnosis of bone metastasis in Patients with Bone Metastases of Differentiated Thyroid Carcinoma.
    Eur J Endocrinol. 2016 Jun 7. pii: EJE-16-0237.
    PubMed     Text format     Abstract available


  50. LAMARTINA L, Deandreis D, Durante C, Filetti S, et al
    ENDOCRINE TUMOURS: Imaging in the follow up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach.
    Eur J Endocrinol. 2016 Jun 1. pii: EJE-16-0088.
    PubMed     Text format     Abstract available


    May 2016
  51. CHILD CJ, Blum WF, Deal C, Zimmermann AG, et al
    Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes.
    Eur J Endocrinol. 2016;174:669-79.
    PubMed     Text format     Abstract available


    April 2016
  52. CERBONE M, Capalbo D, Wasniewska M, Alfano S, et al
    Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism.
    Eur J Endocrinol. 2016 Apr 11. pii: EJE-15-0833.
    PubMed     Text format     Abstract available


  53. SOGAARD M, Farkas DK, Ehrenstein V, Jorgensen JO, et al
    Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study.
    Eur J Endocrinol. 2016;174:409-14.
    PubMed     Text format     Abstract available


    March 2016
  54. PROVENZALE MA, Fiore E, Ugolini C, Torregrossa L, et al
    "Incidental" and "non-incidental" thyroid papillary microcarcinomas are two different entities.
    Eur J Endocrinol. 2016 Mar 31. pii: EJE-15-1223.
    PubMed     Text format     Abstract available


  55. PICCARDO A, Puntoni M, Treglia G, Foppiani L, et al
    Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
    Eur J Endocrinol. 2016 Mar 10. pii: EJE-15-1199.
    PubMed     Text format     Abstract available


  56. ELBERS LP, Moran C, Gerdes VE, van Zaane B, et al
    The Hypercoagulable state in Hyperthyroidism is mediated via the Thyroid Hormone beta Receptor pathway.
    Eur J Endocrinol. 2016 Mar 9. pii: EJE-15-1249.
    PubMed     Text format     Abstract available


  57. HOERMANN R, Larisch R, Dietrich JW, Midgley JE, et al
    Derivation of a Multivariate Reference Range for Pituitary Thyrotropin and Thyroid Hormones: Diagnostic Efficiency Compared to Conventional Single Reference Method.
    Eur J Endocrinol. 2016 Mar 7. pii: EJE-16-0031.
    PubMed     Text format     Abstract available


  58. ATES I, Altay M, Yilmaz FM, Topcuoglu C, et al
    The Impact of Levothyroxine Sodium Treatment on Oxidative Stress in Hashimoto's Thyroiditis.
    Eur J Endocrinol. 2016 Mar 7. pii: EJE-15-1061.
    PubMed     Text format     Abstract available


    February 2016
  59. VALDERRABANO P, Leon ME, Centeno BA, Otto KJ, et al
    Institutional prevalence of malignancy of indeterminate thyroid cytology is necessary but insufficient to accurately interpret molecular marker tests.
    Eur J Endocrinol. 2016 Feb 22. pii: EJE-15-1163.
    PubMed     Text format     Abstract available


  60. HAGLUND F, Juhlin CC, Kiss NB, Larsson C, et al
    Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones.
    Eur J Endocrinol. 2016 Feb 10. pii: EJE-15-1062.
    PubMed     Text format     Abstract available


  61. ILIADOU PK, Effraimidis G, Konstantinos M, Grigorios P, et al
    Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents.
    Eur J Endocrinol. 2016;174:X1.
    PubMed     Text format    


  62. FROHLICH E, Wahl R
    MECHANISMS IN ENDOCRINOLOGY: Impact of isolated TSH levels in and out of normal range on different tissues.
    Eur J Endocrinol. 2016;174:R29-41.
    PubMed     Text format     Abstract available


    January 2016
  63. FERREIRA LB, Eloy K, Pestana A, Lyra J, et al
    Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.
    Eur J Endocrinol. 2016 Jan 25. pii: EJE-15-0577.
    PubMed     Text format     Abstract available


  64. TAIEB D, Bournaud C, Eberle MC, Catargi B, et al
    Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled study.
    Eur J Endocrinol. 2016 Jan 15. pii: EJE-15-1099.
    PubMed     Text format     Abstract available


  65. LLAVERO-VALERO M, Guillen-Grima F, Zafon C, Galofre JC, et al
    THE PLACEBO EFFECT IN THYROID CANCER: A META-ANALYSIS.
    Eur J Endocrinol. 2016 Jan 13. pii: EJE-15-1119.
    PubMed     Text format     Abstract available


  66. MARUO Y, Nagasaki K, Matsui K, Mimura Y, et al
    Natural course of congenital hypothyroidism by dual oxidase 2 mutations from the neonatal period through puberty.
    Eur J Endocrinol. 2016 Jan 7. pii: EJE-15-0959.
    PubMed     Text format     Abstract available


  67. KNIGHT BA, Shields BM, Hattersley AT, Vaidya B, et al
    Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters.
    Eur J Endocrinol. 2016;174:51-7.
    PubMed     Text format     Abstract available


  68. HATTORI N, Ishihara T, Shimatsu A
    Variability in the detection of macro TSH in different immunoassay systems.
    Eur J Endocrinol. 2016;174:9-15.
    PubMed     Text format     Abstract available


    December 2015
  69. ZEVENBERGEN C, Korevaar T, Schuette A, Peeters RP, et al
    ASSOCIATION OF ANTIEPILEPTIC DRUG USAGE, TRACE ELEMENTS AND THYROID HORMONE STATUS.
    Eur J Endocrinol. 2015 Dec 23. pii: EJE-15-1081.
    PubMed     Text format     Abstract available


  70. BIKAS A, Kundra P, Desale S, Mete M, et al
    Phase II Clinical Trial of Sunitinib as Adjunctive Treatment in Patients with Advanced Differentiated Thyroid Cancer.
    Eur J Endocrinol. 2015 Dec 15. pii: EJE-15-0930.
    PubMed     Text format     Abstract available


    November 2015
  71. ANDERSEN SL, Olsen J, Laurberg P
    Maternal thyroid disease in the Danish National Birth Cohort: prevalence and risk factors.
    Eur J Endocrinol. 2015 Nov 18. pii: EJE-15-0816.
    PubMed     Text format     Abstract available


  72. BRANDT F, Thvilum M, Hegedus L, Brix TH, et al
    Hyperthyroidism is associated with work disability and loss of labour market income. A Danish register-based study in singletons and disease-discordant twin pairs.
    Eur J Endocrinol. 2015;173:595-602.
    PubMed     Text format     Abstract available


  73. NOTEN AM, Loomans EM, Vrijkotte TG, van de Ven PM, et al
    Maternal hypothyroxinaemia in early pregnancy and school performance in 5-year-old offspring.
    Eur J Endocrinol. 2015;173:563-71.
    PubMed     Text format     Abstract available


    October 2015
  74. TAVARES C, Melo M, Cameselle Teijeiro JM, Soares P, et al
    ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.
    Eur J Endocrinol. 2015 Oct 28. pii: EJE-15-0605.
    PubMed     Text format     Abstract available


  75. NAZARPOUR S, Ramezani Tehrani F, Simbar M, Tohidi M, et al
    Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders.
    Eur J Endocrinol. 2015 Oct 28. pii: EJE-15-0750.
    PubMed     Text format     Abstract available


  76. WOJCICKA A, Kolanowska M, Jazdzewski K
    MECHANISMS IN ENDOCRINOLOGY: MicroRNA in diagnostics and therapy of thyroid cancer.
    Eur J Endocrinol. 2015 Oct 26. pii: EJE-15-0647.
    PubMed     Text format     Abstract available


  77. BONGIOVANNI M, Trimboli P, Rossi ED, Fadda G, et al
    DIAGNOSIS OF ENDOCRINE DISEASE: High-yield thyroid fine-needle aspiration cytology: an update focused on ancillary techniques improving its accuracy.
    Eur J Endocrinol. 2015 Oct 8. pii: EJE-15-0817.
    PubMed     Text format     Abstract available


  78. BASTOS AU, Oler G, Nozima BH, Moyses RA, et al
    BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.
    Eur J Endocrinol. 2015;173:525-40.
    PubMed     Text format     Abstract available


  79. BLIDDAL S, Boas M, Hilsted L, Friis-Hansen L, et al
    Thyroid function and autoimmunity in Danish pregnant women after an iodine fortification program and associations with obstetric outcomes.
    Eur J Endocrinol. 2015;173:425-34.
    PubMed     Text format     Abstract available


    September 2015
  80. HANDKIEIWCZ-JUNAK D, Gawlik T, Roskosz J, Puch Z, et al
    Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer.
    Eur J Endocrinol. 2015 Sep 30. pii: EJE-15-0562.
    PubMed     Text format     Abstract available


  81. WASNIEWSKA M, Aversa T, Salerno M, Corrias A, et al
    Five-year prospective evaluation of thyroid function in girls with subclinical mild hypothyroidism of different etiology.
    Eur J Endocrinol. 2015 Sep 15. pii: EJE-15-0484.
    PubMed     Text format     Abstract available


  82. ILIADOU PK, Effraimidis G, Michalakis K, Panagiotou G, et al
    Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents.
    Eur J Endocrinol. 2015 Sep 14. pii: EJE-14-1046.
    PubMed     Text format     Abstract available


  83. ATES I, Yilmaz FM, Altay M, Yilmaz N, et al
    The Relationship between Oxidative Stress and Autoimmunity in Hashimoto's Thyroiditis.
    Eur J Endocrinol. 2015 Sep 4. pii: EJE-15-0617.
    PubMed     Text format     Abstract available


  84. MIRZA F, Canalis E
    Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.
    Eur J Endocrinol. 2015;173:R131-51.
    PubMed     Text format     Abstract available


    August 2015
  85. KLOOKER TK, Huibers A, In 't Hof K, Nieveen van Dijkum EJ, et al
    Screw needle cytology of thyroid nodules is associated with a lower non-diagnostic rate compared to fine needle aspiration.
    Eur J Endocrinol. 2015 Aug 26. pii: EJE-15-0337.
    PubMed     Text format     Abstract available


  86. LAMBRINOUDAKI I, Armeni E, Rizos D, Georgiopoulos G, et al
    Indices of adiposity and thyroid hormones in euthyroid postmenopausal women.
    Eur J Endocrinol. 2015;173:237-45.
    PubMed     Text format     Abstract available


  87. POTGIESER PW, Wiersinga WM, Regensburg NI, Mourits MP, et al
    Some studies on the natural history of Graves' orbitopathy: increase in orbital fat is a rather late phenomenon.
    Eur J Endocrinol. 2015;173:149-53.
    PubMed     Text format     Abstract available


  88. GEBAUER J, Fick EM, Waldmann A, Langer T, et al
    Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany.
    Eur J Endocrinol. 2015;173:139-48.
    PubMed     Text format     Abstract available


    July 2015
  89. COENE KL, Demir A, Broeren MA, Verschuure P, et al
    Subclinical hypothyroidism: a 'laboratory-induced' condition?
    Eur J Endocrinol. 2015 Jul 28. pii: EJE-15-0684.
    PubMed     Text format     Abstract available


  90. JO K, Kim MH, Lim Y, Jung SL, et al
    Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.
    Eur J Endocrinol. 2015 Jul 24. pii: EJE-15-0344.
    PubMed     Text format     Abstract available


  91. KELDERMAN-BOLK N, Visser TJ, Tijssen JG, Berghout A, et al
    Quality of life in patients with primary hypothyroidism is related to BMI.
    Eur J Endocrinol. 2015 Jul 13. pii: EJE-15-0395.
    PubMed     Text format     Abstract available


  92. BUSNELLI A, Vannucchi G, Paffoni A, Faulisi S, et al
    Levothyroxine dose adjustment in hypothyroid women achieving pregnancy through IVF.
    Eur J Endocrinol. 2015 Jul 2. pii: EJE-15-0151.
    PubMed     Text format     Abstract available


    June 2015
  93. LANG B, Wong CK
    A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma (PTMC).
    Eur J Endocrinol. 2015 Jun 23. pii: EJE-15-0454.
    PubMed     Text format     Abstract available


  94. SONG HJ, Qiu ZL, Shen CT, Wei WJ, et al
    Pulmonary Metastases in Differentiated Thyroid Cancer: Efficacy of Radioiodine Therapy and Prognostic Factors.
    Eur J Endocrinol. 2015 Jun 23. pii: EJE-15-0296.
    PubMed     Text format     Abstract available


  95. DEL DUCA SC, Santaguida MG, Brusca N, Gatto I, et al
    INDIVIDUALLY-TAILORED THYROXINE REQUIREMENT IN THE SAME PATIENTS BEFORE AND AFTER THYROIDECTOMY: A LONGITUDINAL STUDY.
    Eur J Endocrinol. 2015 Jun 19. pii: EJE-15-0314.
    PubMed     Text format     Abstract available


  96. SITGES-SERRA A, Lorente L, Mateu G, Sancho J, et al
    THERAPY OF ENDOCRINE DISEASE: CENTRAL NECK DISSECTION: A STEP FORWARD IN THE TREATMENT OF PAPILLARY THYROID CANCER.
    Eur J Endocrinol. 2015 Jun 18. pii: EJE-15-0481.
    PubMed     Text format     Abstract available


  97. ITO M, Miyauchi A, Kang S, Hisakado M, et al
    Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    Eur J Endocrinol. 2015 Jun 15. pii: EJE-15-0138.
    PubMed     Text format     Abstract available


  98. LA COUR JL, Jensen LT, Vej-Hansen A, Nygaard B, et al
    Radioiodine therapy increases the risk of cerebrovascular events in hyperthyroid and euthyroid patients.
    Eur J Endocrinol. 2015;172:771-8.
    PubMed     Text format     Abstract available


  99. ELISEI R, Lorusso L, Piaggi P, Torregrossa L, et al
    An elevated serum levels of Carbohydrate Antigen 19.9 (Ca 19.9) is a prognostic factor of death in patients with advanced medullary thyroid cancer.
    Eur J Endocrinol. 2015 Jun 1. pii: EJE-15-0304.
    PubMed     Text format     Abstract available


    May 2015
  100. HIRATA Y, Fukuoka H, Iguchi G, Iwahashi Y, et al
    Median-lower normal levels of serum thyroxine are associated with low triiodothyronine levels and body temperature in patients with central hypothyroidism.
    Eur J Endocrinol. 2015 May 20. pii: EJE-15-0130.
    PubMed     Text format     Abstract available


  101. SALVATORI M, Biondi B, Rufini V
    IMAGING IN ENDOCRINOLOGY: 18F-FDG PET/CT in differentiated thyroid carcinoma: clinical indications and controversies in the diagnosis and follow- up of differentiated thyroid cancer.
    Eur J Endocrinol. 2015 May 6. pii: EJE-15-0066.
    PubMed     Text format     Abstract available


  102. AKYUREK O, Efe D, Kaya Z
    Thoracic periaortic adipose tissue is increased in patients with subclinical hypothyroidism.
    Eur J Endocrinol. 2015;172:553-9.
    PubMed     Text format     Abstract available


    April 2015
  103. CIRELLO V, Rizzo R, Crippa M, Campi I, et al
    FETAL CELL MICROCHIMERISM: A PROTECTIVE ROLE IN AUTOIMMUNE THYROID DISEASES.
    Eur J Endocrinol. 2015 Apr 27. pii: EJE-15-0028.
    PubMed     Text format     Abstract available


  104. LERSTAD G, Enga K, Jorde R, Brodin E, et al
    Thyroid function, assessed by thyroid stimulating hormone, and future risk of venous thromboembolism -The Tromso study.
    Eur J Endocrinol. 2015 Apr 21. pii: EJE-15-0185.
    PubMed     Text format     Abstract available


  105. VANNUCCHI G, De Leo S, Perrino M, Rossi S, et al
    IMPACT OF ESTROGEN AND PROGESTERONE RECEPTORS EXPRESSION ON THE CLINICAL AND MOLECULAR FEATURES OF PAPILLARY THYROID CANCER.
    Eur J Endocrinol. 2015 Apr 10. pii: EJE-15-0054.
    PubMed     Text format     Abstract available


  106. CUESTAS E, Gaido MI, Capra RH
    Transient neonatal hyperthyrotropinemia is a risk factor for developing persistent hyperthyrotropinemia in childhood with repercussion on developmental status.
    Eur J Endocrinol. 2015;172:483-90.
    PubMed     Text format     Abstract available


    March 2015
  107. HARVENGT J, Boizeau P, Chevenne D, Zenaty D, et al
    Triiodothyronine-predominant Graves' disease (T3-P-GD) in childhood: detection and therapeutic implications.
    Eur J Endocrinol. 2015 Mar 12. pii: EJE-14-0959.
    PubMed     Text format     Abstract available


  108. WINTHER KH, Bonnema SJ, Cold F, Debrabant B, et al
    Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population.
    Eur J Endocrinol. 2015 Mar 4. pii: EJE-15-0069.
    PubMed     Text format     Abstract available


  109. SISTI E, Coco B, Menconi F, Leo M, et al
    Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.
    Eur J Endocrinol. 2015;172:269-76.
    PubMed     Text format     Abstract available


    February 2015
  110. COLATO C, Vicentini C, Cantara S, Pedron S, et al
    Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.
    Eur J Endocrinol. 2015 Feb 19. pii: EJE-14-0930.
    PubMed     Text format     Abstract available


  111. BRABANT G, Peeters R, Chan S, Bernal J, et al
    Management of subclinical hypothyroidism in pregnancy - Are we too simplistic?
    Eur J Endocrinol. 2015 Feb 3. pii: EJE-14-1005.
    PubMed     Text format     Abstract available


  112. CURTO L, Giovinazzo S, Alibrandi A, Campenni A, et al
    EFFECTS OF GH REPLACEMENT THERAPY ON THYROID VOLUME AND NODULE DEVELOPMENT IN GROWTH HORMONE DEFICIENT ADULTS: A RETROSPECTIVE COHORT STUDY.
    Eur J Endocrinol. 2015 Feb 2. pii: EJE-14-0966.
    PubMed     Text format     Abstract available


  113. BARBOSA AP, Rui Mascarenhas M, Silva CF, Tavora I, et al
    Prevalence of silent vertebral fractures detected by vertebral fracture assessment in young Portuguese men with hyperthyroidism.
    Eur J Endocrinol. 2015;172:189-94.
    PubMed     Text format     Abstract available


  114. SOH LM, Druce M, Grossman AB, Differ AM, et al
    Evaluation of genotype-phenotype relationships in patients referred for endocrine assessment in suspected Pendred syndrome.
    Eur J Endocrinol. 2015;172:217-26.
    PubMed     Text format     Abstract available


    January 2015
  115. HORACEK J, Maly J, Svilias I, Smolej L, et al
    Prothrombotic changes due to an increase in thyroid hormone levels.
    Eur J Endocrinol. 2015 Jan 30. pii: EJE-14-0801.
    PubMed     Text format     Abstract available


  116. WANG X, Cheng W, Li J, Su A, et al
    Familial nomeduallary thyroid carcinoma is a more aggressive disease: A systematic review and meta-analysis.
    Eur J Endocrinol. 2015 Jan 30. pii: EJE-14-0960.
    PubMed     Text format     Abstract available


  117. LINKS TP, Verbeek HH, Hofstra RM, Plukker J, et al
    ENDOCRINE TUMOURS: Progressive metastatic medullary thyroid carcinoma: first and second line strategies.
    Eur J Endocrinol. 2015 Jan 27. pii: EJE-14-0726.
    PubMed     Text format     Abstract available


  118. SARIKA L, Papathoma A, Garofalaki M, Saltiki K, et al
    Genetic screening of patients with Medullary Thyroid Cancer (MTC) in a referral center in Greece during the past two decades.
    Eur J Endocrinol. 2015 Jan 26. pii: EJE-14-0817.
    PubMed     Text format     Abstract available


  119. ARENA S, Latina A, Baratta R, Burgio G, et al
    Chronic Lymphocytic Thyroiditis (CLT): could it be influenced by a petrochemical complex? Data from a cytological study in South-Eastern Sicily.
    Eur J Endocrinol. 2015 Jan 19. pii: EJE-14-0864.
    PubMed     Text format     Abstract available


  120. GANDOLFI G, Ragazzi M, Frasoldati A, Piana S, et al
    TERT promoter mutations are associated with distant metastases in Papillary Thyroid Carcinoma.
    Eur J Endocrinol. 2015 Jan 12. pii: EJE-14-0837.
    PubMed     Text format     Abstract available


  121. KLEIN HESSELINK EN, Steenvoorden D, Kapiteijn E, Corssmit EP, et al
    THERAPY OF ENDOCRINE DISEASE: Response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: systematic review and meta-analysis.
    Eur J Endocrinol. 2015 Jan 8. pii: EJE-14-0788.
    PubMed     Text format     Abstract available


  122. LODEWIJK L, Bongers PJ, Kist JW, Conemans EB, et al
    Thyroid incidentalomas in patients with Multiple Endocrine Neoplasia type 1.
    Eur J Endocrinol. 2015 Jan 8. pii: EJE-14-0897.
    PubMed     Text format     Abstract available


  123. GABERSCEK S, Zaletel K, Schwetz V, Pieber T, et al
    MECHANISMS IN ENDOCRINOLOGY: Thyroid and polycystic ovary syndrome.
    Eur J Endocrinol. 2015;172:R9-R21.
    PubMed     Text format     Abstract available


    December 2014
  124. LIU X, Qiang W, Liu X, Liu L, et al
    A second course of antithyroid drug therapy for recurrent Graves' disease: An experience in endocrine practice.
    Eur J Endocrinol. 2014 Dec 2. pii: EJE-14-0704.
    PubMed     Text format     Abstract available


  125. ITTERMANN T, Khattak R, Nauck M, Cordova C, et al
    Shift of the Thyroid-Stimulating Hormone Reference Range with Improved Iodine Supply in Northeast Germany.
    Eur J Endocrinol. 2014 Dec 1. pii: EJE-14-0898.
    PubMed     Text format     Abstract available


  126. BARBIERI RB, Bufalo NE, Secolin R, Assumpcao LV, et al
    Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.
    Eur J Endocrinol. 2014;171:761-7.
    PubMed     Text format     Abstract available


    November 2014
  127. PEREZ-LOBATO R, Ramos R, Arrebola JP, Calvente I, et al
    Thyroid status and its association with cognitive functioning in healthy boys at 10 years of age.
    Eur J Endocrinol. 2014 Nov 13. pii: EJE-14-0093.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: